HYAL1 and neoplasm: Overexpression of HAS1 in prostate cancer was shown to be anti-tumorigenic; however, overexpression of both HAS1 and Hyal-1 increased HA fragmentation that in turn promoted tumor cell proliferation and metastasis (93).